Year |
Citation |
Score |
2021 |
Yi X, Yuan D, Farr SA, Banks WA, Poon CD, Kabanov AV. Corrigendum to "Pluronic modified leptin with increased systemic circulation, brain uptake and efficacy for treatment of obesity" [Journal of Controlled Release 191 (2014) 34-46]. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 34245787 DOI: 10.1016/j.jconrel.2021.07.001 |
0.518 |
|
2018 |
Jiang Y, Fay JM, Poon CD, Vinod N, Zhao Y, Bullock K, Qin S, Manickam DS, Yi X, Banks WA, Kabanov AV. Nanoformulation of Brain-Derived Neurotrophic Factor with Target Receptor-Triggered-Release in the Central Nervous System. Advanced Functional Materials. 28. PMID 29785179 DOI: 10.1002/Adfm.201703982 |
0.628 |
|
2017 |
Li Y, Song X, Yi X, Wang R, Lee SM, Wang X, Zheng Y. Zebrafish: A Visual Model to Evaluate the Biofate of Transferrin Receptor-targeted 7Peptide-decorated Coumarin 6 Micelles. Acs Applied Materials & Interfaces. PMID 29039926 DOI: 10.1021/Acsami.7B12809 |
0.402 |
|
2017 |
Li Y, Chen T, Miao X, Yi X, Wang X, Zhao H, Lee SM, Zheng Y. Zebrafish: A promising in vivo model for assessing the delivery of natural products, fluorescence dyes and drugs across the blood-brain barrier. Pharmacological Research. PMID 28867638 DOI: 10.1016/J.Phrs.2017.08.017 |
0.48 |
|
2017 |
Chen T, Li Y, Li C, Yi X, Wang R, Lee SMY, Zheng Y. Pluronic P85/F68 Micelles of Baicalein Could Interfere with Mitochondria to Overcome MRP2-Mediated Efflux and Offer Improved Anti-Parkinsonian Activity. Molecular Pharmaceutics. PMID 28806519 DOI: 10.1021/Acs.Molpharmaceut.7B00374 |
0.405 |
|
2017 |
Li Y, Miao X, Chen T, Yi X, Wang R, Zhao H, Lee SM, Wang X, Zheng Y. Zebrafish as a visual and dynamic model to study the transport of nanosized drug delivery systems across the biological barriers. Colloids and Surfaces. B, Biointerfaces. 156: 227-235. PMID 28544957 DOI: 10.1016/J.Colsurfb.2017.05.022 |
0.403 |
|
2017 |
Yuan D, Yi X, Zhao Y, Poon CD, Bullock KM, Hansen KM, Salameh TS, Farr SA, Banks WA, Kabanov AV. Intranasal delivery of N-terminal modified leptin-pluronic conjugate for treatment of obesity. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 28344017 DOI: 10.1016/J.Jconrel.2017.03.029 |
0.644 |
|
2016 |
Harris NM, Ritzel R, Mancini N, Jiang Y, Yi X, Manickam DS, Banks WA, Kabanov AV, McCullough LD, Verma R. Nano-particle delivery of brain derived neurotrophic factor after focal cerebral ischemia reduces tissue injury and enhances behavioral recovery. Pharmacology, Biochemistry, and Behavior. PMID 27619636 DOI: 10.1016/J.Pbb.2016.09.003 |
0.565 |
|
2016 |
Chen T, Li Y, Wu W, Yi X, Lee SM, Zheng Y. Enhanced dissolution, oral bioavailability and brain delivery by formulation schisantherin a into nanocrystals Nanomedicine: Nanotechnology, Biology and Medicine. 12: 503. DOI: 10.1016/J.Nano.2015.12.160 |
0.492 |
|
2014 |
Falcone JA, Salameh TS, Yi X, Cordy BJ, Mortell WG, Kabanov AV, Banks WA. Intranasal administration as a route for drug delivery to the brain: evidence for a unique pathway for albumin. The Journal of Pharmacology and Experimental Therapeutics. 351: 54-60. PMID 25027317 DOI: 10.1124/Jpet.114.216705 |
0.62 |
|
2014 |
Yi X, Manickam DS, Brynskikh A, Kabanov AV. Agile delivery of protein therapeutics to CNS. Journal of Controlled Release : Official Journal of the Controlled Release Society. 190: 637-63. PMID 24956489 DOI: 10.1016/J.Jconrel.2014.06.017 |
0.628 |
|
2014 |
Yi X, Yuan D, Farr SA, Banks WA, Poon CD, Kabanov AV. Pluronic modified leptin with increased systemic circulation, brain uptake and efficacy for treatment of obesity. Journal of Controlled Release : Official Journal of the Controlled Release Society. 191: 34-46. PMID 24881856 DOI: 10.1016/J.Jconrel.2014.05.044 |
0.614 |
|
2013 |
Yi X, Kabanov AV. Brain delivery of proteins via their fatty acid and block copolymer modifications. Journal of Drug Targeting. 21: 940-55. PMID 24160902 DOI: 10.3109/1061186X.2013.847098 |
0.654 |
|
2013 |
Tong J, Yi X, Luxenhofer R, Banks WA, Jordan R, Zimmerman MC, Kabanov AV. Conjugates of superoxide dismutase 1 with amphiphilic poly(2-oxazoline) block copolymers for enhanced brain delivery: synthesis, characterization and evaluation in vitro and in vivo. Molecular Pharmaceutics. 10: 360-77. PMID 23163230 DOI: 10.1021/Mp300496X |
0.639 |
|
2011 |
Banks WA, Gertler A, Solomon G, Niv-Spector L, Shpilman M, Yi X, Batrakova E, Vinogradov S, Kabanov AV. Principles of strategic drug delivery to the brain (SDDB): development of anorectic and orexigenic analogs of leptin. Physiology & Behavior. 105: 145-9. PMID 21669216 DOI: 10.1016/J.Physbeh.2011.05.024 |
0.607 |
|
2011 |
Tong J, Zimmerman MC, Li S, Yi X, Luxenhofer R, Jordan R, Kabanov AV. Neuronal uptake and intracellular superoxide scavenging of a fullerene (C60)-poly(2-oxazoline)s nanoformulation. Biomaterials. 32: 3654-65. PMID 21342705 DOI: 10.1016/J.Biomaterials.2011.01.068 |
0.494 |
|
2010 |
Tong J, Luxenhofer R, Yi X, Jordan R, Kabanov AV. Protein modification with amphiphilic block copoly(2-oxazoline)s as a new platform for enhanced cellular delivery. Molecular Pharmaceutics. 7: 984-92. PMID 20550191 DOI: 10.1021/Mp100102P |
0.53 |
|
2010 |
Yi X, Zimmerman MC, Yang R, Tong J, Vinogradov S, Kabanov AV. Pluronic-modified superoxide dismutase 1 attenuates angiotensin II-induced increase in intracellular superoxide in neurons. Free Radical Biology & Medicine. 49: 548-58. PMID 20493251 DOI: 10.1016/J.Freeradbiomed.2010.04.039 |
0.519 |
|
2010 |
Price TO, Farr SA, Yi X, Vinogradov S, Batrakova E, Banks WA, Kabanov AV. Transport across the blood-brain barrier of pluronic leptin. The Journal of Pharmacology and Experimental Therapeutics. 333: 253-63. PMID 20053933 DOI: 10.1124/Jpet.109.158147 |
0.601 |
|
2008 |
Yi X, Batrakova E, Banks WA, Vinogradov S, Kabanov AV. Protein conjugation with amphiphilic block copolymers for enhanced cellular delivery. Bioconjugate Chemistry. 19: 1071-7. PMID 18447367 DOI: 10.1021/Bc700443K |
0.601 |
|
2008 |
Gilmore JL, Yi X, Quan L, Kabanov AV. Novel nanomaterials for clinical neuroscience. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 3: 83-94. PMID 18210200 DOI: 10.1007/S11481-007-9099-6 |
0.605 |
|
Show low-probability matches. |